A tighter archive for life-science signals.
Search once, then narrow by source or topic.
In the clinic for Feb. 10, 2026
In the clinic for Feb. 10, 2026
Other news to note for Feb. 10, 2026
Other news to note for Feb. 10, 2026
Regulatory actions for Feb. 10, 2026
Regulatory actions for Feb. 10, 2026
Pharma company, execs charged with securities fraud
Pharma company, execs charged with securities fraud
2026 kicks off with $10.8B January financing haul
2026 kicks off with $10.8B January financing haul
Iambic raises the bard in AI, pens $1.7B Takeda deal
Iambic raises the bard in AI, pens $1.7B Takeda deal
China amends drug rules to enforce lifecycle accountability
China amends drug rules to enforce lifecycle accountability
AI meets antibody design: Galux draws $29M series B for drug R&D
AI meets antibody design: Galux draws $29M series B for drug R&D
Innovent-Lilly $8.5B deal signals new China inflection point
Innovent-Lilly $8.5B deal signals new China inflection point
In the clinic for Feb. 10, 2026
In the clinic for Feb. 10, 2026
Appointments and advancements for Feb. 10, 2026
Appointments and advancements for Feb. 10, 2026
Financings for Feb. 10, 2026
Financings for Feb. 10, 2026
Regulatory actions for Feb. 10, 2026
Regulatory actions for Feb. 10, 2026
Holiday notice
Holiday notice
Appointments and advancements for Feb. 9, 2026
Appointments and advancements for Feb. 9, 2026
Financings for Feb. 9, 2026
Financings for Feb. 9, 2026
In the clinic for Feb. 9, 2026
In the clinic for Feb. 9, 2026
Other news to note for Feb. 9, 2026
Other news to note for Feb. 9, 2026
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page